142 related articles for article (PubMed ID: 9116912)
21. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.
Eriksson J; Franssila-Kallunki A; Ekstrand A; Saloranta C; Widén E; Schalin C; Groop L
N Engl J Med; 1989 Aug; 321(6):337-43. PubMed ID: 2664520
[TBL] [Abstract][Full Text] [Related]
22. Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM.
Shoji T; Nishizawa Y; Emoto M; Maekawa K; Hiura Y; Tanaka S; Kawagishi T; Okuno Y; Morii H
Diabetologia; 1997 Jun; 40(6):676-9. PubMed ID: 9222647
[TBL] [Abstract][Full Text] [Related]
23. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.
Forsblom CM; Eriksson JG; Ekstrand AV; Teppo AM; Taskinen MR; Groop LC
Diabetologia; 1995 Mar; 38(3):363-9. PubMed ID: 7758885
[TBL] [Abstract][Full Text] [Related]
24. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects.
Groop L; Forsblom C; Lehtovirta M; Tuomi T; Karanko S; Nissén M; Ehrnström BO; Forsén B; Isomaa B; Snickars B; Taskinen MR
Diabetes; 1996 Nov; 45(11):1585-93. PubMed ID: 8866565
[TBL] [Abstract][Full Text] [Related]
25. Prandial glucose effectiveness and fasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes.
Nielsen MF; Nyholm B; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Rizza RA; Schmitz O
Diabetes; 2000 Dec; 49(12):2135-41. PubMed ID: 11118017
[TBL] [Abstract][Full Text] [Related]
26. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
27. Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families.
Humphriss DB; Stewart MW; Berrish TS; Barriocanal LA; Trajano LR; Ashworth LA; Brown MD; Miller M; Avery PJ; Alberti KG; Walker M
Diabetologia; 1997 Oct; 40(10):1185-90. PubMed ID: 9349600
[TBL] [Abstract][Full Text] [Related]
28. Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.
Marita AR; Sarkar JA; Rane S
Mol Cell Biochem; 2005 Jul; 275(1-2):143-51. PubMed ID: 16335794
[TBL] [Abstract][Full Text] [Related]
29. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men.
Eriksson KF; Lindgärde F
Diabetologia; 1996 May; 39(5):573-9. PubMed ID: 8739917
[TBL] [Abstract][Full Text] [Related]
30. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
31. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Henriksen JE; Alford F; Ward GM; Beck-Nielsen H
Diabetologia; 1997 Dec; 40(12):1439-48. PubMed ID: 9447952
[TBL] [Abstract][Full Text] [Related]
32. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
Eriksson JW; Smith U; Waagstein F; Wysocki M; Jansson PA
Diabetes; 1999 Aug; 48(8):1572-8. PubMed ID: 10426375
[TBL] [Abstract][Full Text] [Related]
33. Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus.
Fernández-Castañer M; Biarnés J; Camps I; Ripollés J; Gómez N; Soler J
Diabet Med; 1996 Nov; 13(11):953-9. PubMed ID: 8946153
[TBL] [Abstract][Full Text] [Related]
34. Dodecanedioic acid infusion induces a sparing effect on whole-body glucose uptake, mainly in non-insulin-dependent diabetes mellitus.
Mingrone G; De Gaetano A; Greco AV; Capristo E; Benedetti G; Castagneto M; Gasbarrini G
Br J Nutr; 1997 Nov; 78(5):723-35. PubMed ID: 9389896
[TBL] [Abstract][Full Text] [Related]
35. [Changes of leptin, tumor necrosis factor-alpha, neuropeptide Y levels and their association with insulin resistance and insulin secretion function in normal glucose tolerant first-degree relatives of familial type 2 diabetic pedigrees].
Ren Y; Li X; Tian H; Liang J; Zhang X; Yu H; Wang J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1341-5. PubMed ID: 21374991
[TBL] [Abstract][Full Text] [Related]
36. Features of syndrome X in first-degree relatives of NIDDM patients.
Stewart MW; Humphriss DB; Berrish TS; Barriocanal LA; Trajano LR; Alberti KG; Walker M
Diabetes Care; 1995 Jul; 18(7):1020-2. PubMed ID: 7555535
[TBL] [Abstract][Full Text] [Related]
37. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
Widén EI; Eriksson JG; Groop LC
Diabetes; 1992 Mar; 41(3):354-8. PubMed ID: 1551495
[TBL] [Abstract][Full Text] [Related]
38. Impact of family history of diabetes on the assessment of beta-cell function.
Alford FP; Henriksen JE; Rantzau C; Vaag A; Hew LF; Ward GM; Beck-Nielsen H
Metabolism; 1998 May; 47(5):522-8. PubMed ID: 9591741
[TBL] [Abstract][Full Text] [Related]
39. Glucose tolerance in rural diabetic Thais, first-degree relatives and non-diabetic controls.
Davis TM; Pramukkul P; Suputtamongkol Y; Chaowagul W; Levy J
Diabetes Res Clin Pract; 1995 Mar; 27(3):171-80. PubMed ID: 7555598
[TBL] [Abstract][Full Text] [Related]
40. Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.
Johanson EH; Jansson PA; Lönn L; Matsuzawa Y; Funahashi T; Taskinen MR; Smith U; Axelsen M
J Clin Endocrinol Metab; 2003 Sep; 88(9):4232-8. PubMed ID: 12970292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
